The FDA is planning to make another COVID-19 booster that targets omicron available for high-risk individuals, The Washington Post reported April 3.
Under the authorization, people 65 and older and those with weakened immune systems would be eligible to receive a booster dose four months after their last bivalent shot.
The policy will be "permissive," meaning the agency will allow people to get another booster but will not definitively recommend it, sources familiar with the matter told the Post.
The FDA is expected to announce the plan within several weeks, and the CDC is expected to quickly endorse it, sources said.
Learn more here.